ESC Professional Premium Access

Activation of beta3-AR with mirabegron in hypertrophic cardiomyopathy: the BETA3LVH trial.

Congress Session

About the speaker

Associate Professor Rolf Wachter

University hospital Leipzig AoR, Leipzig (Germany)
8 presentations
0 follower

3 more presentations in this session

Beta3 adrenergic receptors: where, and what for?

Speaker: Professor J. Balligand (Brussels, BE)

Thumbnail

Mirabegron in patients with pulmonary hypertension: the SPHERE-HF trial.

Speaker: Doctor A. Garcia-Alvarez (Barcelona, ES)

Thumbnail

Mirabegron in peripheral vascular disease: the STAR-PAD trial.

Speaker: Doctor M. Gray (Sydney, AU)

Thumbnail

Access the full session

Beta3 adrenergic agonists in the clinic: the end of the beginning

Speakers: Associate Professor R. Wachter, Professor J. Balligand, Doctor A. Garcia-Alvarez, Doctor M. Gray
Thumbnail

About the event

Image

ESC Congress 2022

26 August - 29 August 2022

Sessions Presentations

This platform is supported by

logo Novo Nordisk